Tissue-specific analysis of glycogen synthase kinase-3α (GSK-3α) in glucose metabolism: Effect of strain variation

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Patel, Satish ^a   Macaulay, Katrina ^a   Woodgett, James R ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOGEN SYNTHASE KINASE 3ALPHA; INSULIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 ALPHA; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; GENE DELETION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIVER PARENCHYMA; MOUSE; MUSCLE TISSUE; NONHUMAN; OUTBRED STRAIN; PHENOTYPE; SKELETAL MUSCLE; STRAIN DIFFERENCE; TISSUE SPECIFICITY; WILD TYPE; ANIMAL; LIVER; METABOLISM; MUSCLE; PHYSIOLOGY; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

ANIMALIA; MUS; RODENTIA;

ANIMALS; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; LIVER; MICE; MUSCLES; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

EID: 79251544548     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015845     Document Type: Article

References (27)

1. Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. Embo J 9: 2431-2438.
2. Eldar-Finkelman H (2002) Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 8: 126-132.
3. Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, et al. (2002) Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51: 2190-2198.
4. Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, et al. (2002) Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51: 2903-2910.
5. Dokken BB, Henriksen EJ (2006) Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats. Am J Physiol Endocrinol Metab 291: E207-213.
6. Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, et al. (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52: 588-595.
7. Kaidanovich-Beilin O, Eldar-Finkelman H (2006) Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle. J Pharmacol Exp Ther 316: 17-24.
8. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, et al. (2005) Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. Embo J 24: 1571-1583.
9. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, et al. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86-90.
10. Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, et al. (2008) Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest 118: 3609-3618.
11. MacAulay K, Doble BW, Patel S, Hansotia T, Sinclair EM, et al. (2007) Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab 6: 329-337.
12. Patel S, Doble BW, MacAulay K, Sinclair EM, Drucker DJ, et al. (2008) Tissuespecific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action. Mol Cell Biol 28: 6314-6328.
13. Tanabe K, Liu Z, Patel S, Doble BW, Li L, et al. (2008) Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance. PLoS Biol 6: e37.
14. Bothe GW, Haspel JA, Smith CL, Wiener HH, Burden SJ (2000) Selective expression of Cre recombinase in skeletal muscle fibers. Genesis 26: 165-166.
15. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, et al. (1999) Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274: 305-315.
16. Thomas JA, Schlender KK, Larner J (1968) A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem 25: 486-499.
17. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR (2007) Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 12: 957-971.
18. Lawrence JC, Jr., Roach PJ (1997) New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46: 541-547.
19. MacAulay K, Woodgett JR (2008) Targeting glycogen synthase kinase-3 (GSK- 3) in the treatment of Type 2 diabetes. Expert Opin Ther Targets 12: 1265-1274.
20. Luo J, Quan J, Tsai J, Hobensack CK, Sullivan C, et al. (1998) Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism 47: 663-668.
21. Plum L, Belgardt BF, Bruning JC (2006) Central insulin action in energy and glucose homeostasis. J Clin Invest 116: 1761-1766.
22. Choudhury AI, Heffron H, Smith MA, Al-Qassab H, Xu AW, et al. (2005) The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest 115: 940-950.
23. Kubota N, Terauchi Y, Tobe K, Yano W, Suzuki R, et al. (2004) Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 114: 917-927.
24. Lin X, Taguchi A, Park S, Kushner JA, Li F, et al. (2004) Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114: 908-916.
25. Konner AC, Janoschek R, Plum L, Jordan SD, Rother E, et al. (2007) Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab 5: 438-449.
26. Obici S, Zhang BB, Karkanias G, Rossetti L (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8: 1376-1382.
27. Pocai A, Obici S, Schwartz GJ, Rossetti L (2005) A brain-liver circuit regulates glucose homeostasis. Cell Metab 1: 53-61.